Hypera S.A. (OTCMKTS:HYPMY – Get Free Report)’s stock price crossed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $3.24 and traded as high as $3.68. Hypera shares last traded at $3.68, with a volume of 178 shares changing hands.
Hypera Stock Performance
The company has a current ratio of 1.81, a quick ratio of 1.41 and a debt-to-equity ratio of 0.68. The firm has a 50-day moving average of $3.24 and a 200 day moving average of $3.76.
Hypera Company Profile
Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
Featured Stories
- Five stocks we like better than Hypera
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- ESG Stocks, What Investors Should Know
- 3 Must-Own Stocks to Build Wealth This Decade
- How to Use the MarketBeat Excel Dividend Calculator
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Receive News & Ratings for Hypera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypera and related companies with MarketBeat.com's FREE daily email newsletter.
